Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk

被引：0
|
作者：
Jin You Kim
Jin Joo Kim
Lee Hwangbo
Ji Won Lee
Nam Kyung Lee
Kyung Jin Nam
Ki Seok Choo
Taewoo Kang
Heeseung Park
Yohan Son
Robert Grimm
机构：
[1] Pusan National University Hospital,Department of Radiology, Medical Research Institute
[2] Pusan National University School of Medicine,Department of Radiology
[3] Pusan National University Yangsan Hospital,Department of Radiology
[4] Pusan National University Hospital,Busan Cancer Center
[5] Siemens Healthineers Ltd.,undefined
[6] Siemens Healthcare GmbH,undefined
来源：
European Radiology | 2020年 / 30卷
关键词：
Diffusion magnetic resonance imaging; Breast neoplasms, Oncotype DX; Recurrence; Biomarkers;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：66 / 76
页数：10
相关论文
共 50 条
  • [1] Diffusion-weighted MRI of estrogen receptor-positive, HER2-negative, node-negative breast cancer: association between intratumoral heterogeneity and recurrence risk
    Kim, Jin You
    Kim, Jin Joo
    Hwangbo, Lee
    Lee, Ji Won
    Lee, Nam Kyung
    Nam, Kyung Jin
    Choo, Ki Seok
    Kang, Taewoo
    Park, Heeseung
    Son, Yohan
    Grimm, Robert
    EUROPEAN RADIOLOGY, 2020, 30 (01) : 66 - 76
  • [2] Prognostic stratification of oestrogen receptor-positive HER2-negative lymph node-negative class of breast cancer
    Rakha, Emad A.
    Agarwal, Devika
    Green, Andrew R.
    Ashankyty, Ibraheem
    Ellis, Ian O.
    Ball, Graham
    Alaskandarany, Mohammed A.
    HISTOPATHOLOGY, 2017, 70 (04) : 622 - 631
  • [3] Evaluation of Prognosis in Hormone Receptor-Positive/HER2-Negative and Lymph Node-Negative Breast Cancer With Low Oncotype DX Recurrence Score
    Meisel, Jane
    Zhang, Chao
    Neely, Cameron
    Menduza, Pia
    You, Shuo
    Han, Tatiana
    Liu, Yuan
    Sahin, Aysegul A.
    O'Regan, Ruth
    Li, Xiaoxian
    CLINICAL BREAST CANCER, 2018, 18 (05) : 347 - 352
  • [4] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (12): : 1176 - 1177
  • [5] Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer
    Burstein, Harold J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (26): : 2557 - 2570
  • [6] Association between androgen receptor expression, Ki-67 and the 21-gene recurrence score in non-metastatic, lymph node-negative, estrogen receptor-positive and HER2-negative breast cancer
    Vera-Badillo, Francisco E.
    Chang, Martin C.
    Kuruzar, Gordana
    Ocana, Alberto
    Templeton, Arnoud J.
    Seruga, Bostjan
    Goldstein, Robyn
    Bedard, Philippe L.
    Tannock, Ian F.
    Amir, Eitan
    JOURNAL OF CLINICAL PATHOLOGY, 2015, 68 (10) : 839 - 843
  • [7] Association of endocrine therapy with overall survival in women with hormone receptor-positive, HER2-negative, node-negative breast cancer of favorable histology
    Oladeru, Oluwadamilola T.
    Singh, Anurag K.
    Ma, Sung Jun
    BREAST JOURNAL, 2020, 26 (10): : 2006 - 2010
  • [8] Association Between Neutrophil-Lymphocyte Ratio and Oncotype Dx Recurrence Score in Early-Stage Hormonal Receptor-Positive, HER2-Negative, Node-Negative Breast Cancer
    Alshamsan, Bader
    Alshibany, Aisha
    Elshenawy, Mahmoud A.
    Badran, Ahmed
    Elhassan, Tusneem
    Ajarim, Dahish
    Alsayed, Adher
    Suleman, Kausar
    Al-Tweigeri, Taher
    CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 9411 - 9420
  • [9] Palbociclib for the Treatment of Estrogen Receptor-Positive, HER2-Negative Metastatic Breast Cancer
    Morikawa, Aki
    Henry, N. Lynn
    CLINICAL CANCER RESEARCH, 2015, 21 (16) : 3591 - 3596
  • [10] Adjuvant Chemotherapy Decisions in Clinical Practice for Early-Stage Node-Negative, Estrogen Receptor-Positive, HER2-Negative Breast Cancer: Challenges and Considerations
    Nagaraj, Gayathri
    Ma, Cynthia X.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2013, 11 (03): : 246 - 251
12345